+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Research"

Antibody Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Antibody Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 750 Pages
  • Global
From
From
Oncology Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Oncology Collaboration and Licensing Deals 2019-2024

  • Report
  • October 2024
  • 1800 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

The Cancer Research market is a subset of the Drug Discovery market, focused on the development of treatments for cancer. This market is composed of a variety of stakeholders, including pharmaceutical companies, research institutions, and government agencies. These stakeholders collaborate to develop new treatments and therapies for cancer, as well as to improve existing treatments. The market is driven by the need to find new and effective treatments for cancer, as well as to improve the quality of life for those affected by the disease. The Cancer Research market is highly competitive, with many companies vying for a share of the market. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. These companies are engaged in research and development of new treatments and therapies for cancer, as well as the marketing and distribution of existing treatments. Show Less Read more